Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acyl-Ghrelin on Kidney Function and Blood Pressure
NCT02528422Phase 1Unknown
- Start
- May 2015
- Primary completion
- Jan 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of acyl-ghrelin (3 arms). Primary endpoint: Fractional sodium excretion. Status: unknown.
02
Drugs
acyl-ghrelin
Beyond the preview
Go deeper on NCT02528422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02528422.